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Endothelial dysfunction, with impaired bioavailability and/or bioactivity of the vasoprotective molecule, nitric
oxide, appears to be a vital step in the initiation of atherosclerosis. Several studies have shown that dietary
nitrate/nitrite can have significant benefits on human cardiovascular homeostasis. Although serum nitrite con
centrations can reach micromolar levels, the physiological significance of nitrate/nitrite in normal tissues has not
been fully elucidated. We investigated in vitro the chronic effects of nitrate/nitrite on endothelial nitric oxide
synthase (eNOS) to determine the potential vasoprotective effects of nitrate/nitrite and the underlying molecular
mechanisms. Our results demonstrate the expression of phosphorylated eNOS at Ser1177 and phosphorylated
adenosine monophosphate activated protein kinase (AMPK) at Thr172 in human aortic endothelial cells were
increased after nitrite treatment. We suggest that nitrite stimulation may enhance eNOS activation, which is due,
in part, to AMPK activation. The AMPK–eNOS activation by nitrite may be a possible molecular mechanism
underlying the vascular protective effects of dietary nitrate.

1. Introduction
Cardiovascular disease (CVD) is the leading cause of mortality
worldwide (Roth et al., 2017). The aetiology and pathogenesis of CVD is
multifactorial, including genetic, environmental, dietary and lifestyle
factors (Balakumar, Maung, & Jagadeesh, 2016). Major adverse events
of CVD, such as myocardial infarction and stroke, are predominately due
to reduced and ultimately blocked blood flow in the corresponding tis
sues and organs. This arises secondary to a thickening of the inner layer
of arteries and the formation of obstructive atherosclerotic plaques,
which can impede flow or dislodge and travel elsewhere to block blood
flow (Gimbrone & Garcia-Cardena, 2016). Endothelial dysfunction is
characterised by disturbed vasodilator and anticoagulant function,
increased inflammation and breakdown of barrier function, a vital step
in the initiation of atherosclerosis (Gimbrone & Garcia-Cardena, 2016;
Vanhoutte, Shimokawa, Tang, & Feletou, 2009).
Endothelium-derived nitric oxide (NO) is an important signalling
molecule and is involved in the regulation of cardiovascular homeostasis
(Daiber et al., 2019). NO is a potent vasodilator, it inhibits platelet

activation and aggregation, prevents leucocyte adhesion and migration,
decreases smooth muscle cell proliferation and migration, and sup
presses oxidation of LDL (Cahill & Redmond, 2016). Reduced NO
availability is considered the major cause of endothelial dysfunction. In
the artery wall, NO deficiency activates a series of atherogenic processes
involving: vasoconstriction, adhesion, migration and differentiation of
monocytes, proliferation of smooth muscle cells, thrombosis and
impaired coagulation, and eventually atherosclerosis (Versari, Daghini,
Virdis, Ghiadoni, & Taddei, 2009).
Endothelial nitric oxide synthase (eNOS) is constitutively expressed
in endothelial cells. It converts the amino acid L-arginine into L-citrulline
and NO (Bondonno, Croft, Ward, Considine, & Hodgson, 2015). eNOS
activity is intimately regulated by protein phosphorylation, which is
modulated by kinases, phosphatases and protein–protein interactions
(Kolluru, Siamwala, & Chatterjee, 2010). Phosphorylation of eNOS oc
curs on threonine, tyrosine residues, as well as serine 1177 (Ser1177) in
the reductase domain (Mount, Kemp, & Power, 2007). eNOS is directly
regulated by protein kinase B (Akt) in endothelial cells in response to a
variety of cellular stimuli. Activation of Akt at Ser473 leads to eNOS
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phosphorylation, thereby enhancing eNOS activity, and consequently
increasing NO generation (Sessa, 2004). Metabolic stress can also trigger
the breakdown of ATP, which can stimulate adenosine monophosphateactivated protein kinase (AMPK) to phosphorylate eNOS (Michell et al.,
2002; Sessa, 2004).
Inorganic nitrate and nitrite from endogenous and dietary sources
are emerging as an alternative pathway for NO generation, especially
when the nitric oxide synthase (NOS) pathway is compromised (Lund
berg, Weitzberg, & Gladwin, 2008; Machha & Schechter, 2011). In the
human body, absorbed dietary nitrate is efficiently converted into nitrite
by commensal facultative anaerobic bacteria, and subsequently nitrogen
oxides including NO is formed through reduction of nitrite (Lundberg
et al., 2008). It has been suggested that the nitrate–nitrite–NO pathway
may be critical in maintaining bioactive NO levels and might play a key
role in maintaining cardiovascular homeostasis (Bondonno, Croft, &
Hodgson, 2016).
eNOS is a major contributor to bioactive NO generation and main
tains cardiovascular homeostasis. However, the interactions between
nitrate/nitrite and eNOS under physiological conditions have not been
clarified to date. We hypothesized that eNOS exerts a significant action
in the nitrate-nitrite-NO pathway under normoxic conditions. We
investigated the effects in vitro of chronic treatment with nitrate and
nitrite on eNOS and associated molecules in human aortic endothelial
cells (HAECs) to determine potential molecular mechanisms underlying
the beneficial effects of nitrite and nitrate.

antibodies (1:5000) at room temperature for 1 hr. Proteins were visu
alized using the enhanced chemiluminescence kit (Thermo Fischer Sci
entific, USA) under a ChemiDoc XRS system (Bio-Rad). Protein bands
were analysed using the image lab software (Bio-Rad) and normalized to
the parent protein or Pan-actin.
2.3. Antibodies and chemicals
Antibodies for AKT (#4691), p-AKTSer473 (#4060), AMPKα (#2603),
p-AMPKThr172 (#2535), ACC (#3676), p-ACCSer79 (#3661), Pan-Actin
(#4968) and p-eNOSSer1177 (#9571) were purchased from Cell Signal
ling Technologies (Denvers, MA, USA). Antibodies for eNOS (#610298)
was purchased from BD Biosciences (San Jose, CA, USA). NaNO2,
NaNO3, potassium iodide, iodine, Compound C, L-NAME and AICAR
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Other re
agents were obtained from RPH Medical Research Foundation. Stock
solutions of NaNO2 (20 mM) and NaNO3 (20 mM) were prepared with
fresh Milli-Q water.
2.4. Statistics

2. Materials and methods

All immunoblots shown are the representative results from 4 inde
pendent experiments. Values are presented as means ± SEM. Compari
sons between groups were performed by one-way ANOVA followed by
Tukey–Kramer or Dunnett’s post-hoc test. A value of p < 0.05 was
considered statistically significant. All analyses were carried out using
the GraphPad Prism 7.

2.1. Cell cultures and stimulations

3. Results

HAECs (Lonza Pty Australia) were cultured in commercially avail
able EBM-2 media (Lonza Pty Australia) containing 10% Foetal Bovine
Serum (Corning) in T-75 tissue culture flasks (Thermo Fischer Scientific,
USA). Cells were grown at 37℃ with 5% CO2 and 18.6% O2 in a hu
midified incubator and maintained in a logarithmic growth phase by
routine passages every 2–3 days at a 1:3 split ratio. All experiments were
performed with cells from passage three to nine in 6-well culture plates
(Thermo Fischer Scientific, USA).
The cells were maintained in regular media prior to all experiments.
Following a 4 hr serum starvation, the cells were treated with sodium
nitrite (NaNO2) (final concentration of 0.1 µM and 1 µM) or sodium ni
trate (NaNO3) (final concentration of 1 µM and10 µM) for 30 min or 24
hr. To assess the contribution of eNOS on the response to NaNO2, cells
were pre-incubated with 100 µM N (gamma)-nitro-L-arginine methyl
ester (L-NAME, NOS inhibitor) for 30 min. The role of AMPK in modu
lating eNOS activation was determined by incubation with 20 µM
Compound C (AMPK inhibitor) or 1.25 mM 5-Aminoimidazole-4-car
boxamide ribonucleotide (AICAR, AMPK activator) for 1 hr. At the
end of the treatment periods, cell lysates were collected and stored at
− 80 ℃ until further analysis.

3.1. Effects of nitrite and nitrate on eNOS phosphorylation in HAECs
To confirm eNOS is involved in the actions of nitrite and nitrate, we
determined the level of phosphorylated eNOS at Ser1177. Following
nitrite treatment for 24 hr, the expression of p-eNOS was significantly
increased (Fig. 1). In contrast, treatment of HAECs with nitrate did not
alter the ratio of phosphorylated eNOS/total eNOS (data not shown).
And the level of phosphor-eNOS (Ser 1177) in HAEC stimulated by so
dium nitrate or nitrite for 30 min was not changed (data not shown). To
further confirm the role of eNOS activation, we treated cells with nitrite
in the presence of L-NAME and saw significant reductions in p-eNOS
(Fig. 2).
3.2. Nitrite stimulation induces AMPK activation without Akt activation
As AMPK activation is known to contribute to eNOS phosphorylation
and activation in endothelial cells, we compared the phosphorylation of
AMPK in response to nitrite treatment and observed a significant in
crease in the level of AMPK phosphorylation at Thr172 (Fig. 3). This also
resulted in an increase in eNOS phosphorylation (Fig. 3) and acetyl-CoA
carboxylase (ACC) Ser79 phosphorylation (Fig. 3). In contrast, the level
of phosphorylated Akt was not significantly increased following nitrite
treatment (Fig. 3).

2.2. Immunoblotting
The cells were washed twice with ice-cold PBS then lysed and har
vested in 200 ml Laemmli’s SDS-sample buffer (Bio-Rad, Australia),
containing 250 mM Tris-HCl, 8% SDS, 40% glycerol, 8% β-mercaptoe
thanol, 0.02% bromophenol blue, 5% 2-mercaptoethanol and a phos
phatase inhibitor cocktail (Roche Diagnostics, Australia). Thirty
micrograms of protein per sample was subjected to sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) using 4%–10%
polyacrylamide gels (Bio-Rad, Australia), and transferred onto a nitro
cellulose membrane (GE Healthcare Life Sciences, USA) overnight at
4℃. The membranes were blocked with 5% skim milk for 1 hr at room
temperature and probed with primary antibody overnight at 4℃ (1:500
or 1:1000). Membranes were washed in Tris-buffered saline containing
0.1% Tween followed by incubation with HRP-conjugated secondary

3.3. AMPK lies upstream to the eNOS activation
Compound C, as an inhibitor of AMPK, was used to verify whether
AMPK lies upstream of the eNOS nitrite interaction. The effects of nitrite
on the phosphrylation of AMPK and eNOS were both almost completely
abolished in the presence of Compound C (Fig. 4), suggesting AMPK
activation takes place first.
4. Discussion
NO is one of the most important biological mediators involved in
maintaining vascular homeostasis. In addition to its ability to influence
2
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Fig. 1. The expression and activity of eNOS in HAECs treated with sodium nitrite (0.1 µM and 1 µM, 24hr). (A) Western blot protein expression of total eNOS, eNOS
phosphorylation (Ser1177) and Pan-actin in HAECs. (B) The expression level of p-eNOS and eNOS was measured by the densitometry of the corresponding bands and
normalised to Pan-actin using Image Lab. Values are means ± SEM, n = 4/group, *p < 0.05 vs control. p-eNOS: phosphorylated endothelial nitric oxide synthase;
eNOS: endothelial nitric oxide synthase; HAECs: human aortic endothelial cells.

Fig. 2. The expression and activity of eNOS in HAECs treated with sodium nitrite (1 µM, 24hr) in the presence and absence of L-NAME (100 µM). (A) Western blot
protein expression of total eNOS, phosphorylated eNOS (Ser1177) and Pan-actin in HAECs. (B) The density of the western blotting band analyzed by Image Lab.
Values are means ± SEM, n = 4/group, *p < 0.05 vs control, #p < 0.05 presence of inhibitor vs respective treatment. p-eNOS: phosphorylated endothelial nitric oxide
synthase; eNOS: endothelial nitric oxide synthase; HAECs: human aortic endothelial cells; L-NAME: N-Nitroarginine methyl ester.

basal vascular tone, NO is also recognized as a key determinant of
vascular health by modulating platelet-endothelial interactions, exert
ing antithrombotic, and anti-inflammatory properties within the
vasculature. Impaired NO bioavailability represents the central feature
of endothelial dysfunction, a common abnormality found in many
vascular diseases. Atherosclerosis, hypercholesterolemia, hypertension,
diabetes mellitus, thrombosis and stroke have all been linked to ab
normalities in NO signaling (V. W. T. Liu & Huang, 2008). There are two
major pathways for the NO formation in the body—the endogenous
NOS-dependent system and the exogenous nitrate-nitrite-NO pathway
from dietary uptake of green leafy vegetables (Blekkenhorst et al., 2018;
Bondonno et al., 2016). The dietary pathway is considered a NO reser
voir, which contributes to overall NO availability (Milsom, Fernandez,
Garcia-Saura, Rodriguez, & Feelisch, 2012). Dietary nitrate is converted
to nitrite by anaerobic bacteria in the mouth. The nitrite anion is a cellsignaling molecule, which is considered as a storage pool of NO (Y. Liu,
Croft, Hodgson, Mori, & Ward, 2020). Once formed, nitrite can be uti
lized via various nonenzymatic and enzymatic pathways and converted
to bioactive NO in the circulatory system and tissues (Kim-Shapiro &
Gladwin, 2014; Weitzberg, Hezel, & Lundberg, 2010). Under hypoxic
conditions, nitrite may serve as a substrate for endothelium-derived
generation of NO (Gautier, van Faassen, Mikula, Martasek, & SlamaSchwok, 2006). Here, we suggest a possible new way that diet derived
nitrate/nitrite can activate eNOS in normoxic conditions, with nitrite
increasing eNOS phosphorylation in cultured HAECs. This finding is
consistent with a previous report showing eNOS phosphorylation in
response to treatment with sodium nitrite (Ling, Lau, Murugan, Van
houtte, & Mustafa, 2015).
We used HAECs as a cell model and observed that 0.1 μM to 1 μM
nitrite treatment for 30 min did not significantly change AMPK

phosphorylation and eNOS activation (data not shown). However, with
a prolonged treatment (24 hr), we demonstrated that nitrite activates
AMPK and eNOS. In contrast, a previous study showed that 30 min ni
trite treatment stimulates eNOS phosphorylation in an AMPK dependent
manner in human glomerular endothelial cells (HGEC) (Miyamoto et al.,
2017). However, that study used a higher nitrite concentration (10 μM)
and a different cell line (Miyamoto et al., 2017). The physiological
concentration of nitrite in blood is likely<1 μM (Gladwin et al., 2000).
AMPK is an important monitor of cellular metabolism and energy
homeostasis and regulates almost all aspects of cellular function,
including autophagy, mitochondrial homeostasis, cell polarity, cell
growth and cell proliferation (Hardie, 2011; Mihaylova & Shaw, 2011).
In addition to being activated in response to stimuli that deplete cellular
ATP supplies, including oxidative stress, nutrient deprivation or hyp
oxia, AMPK can also be stimulated following exposure to shear stress,
growth factors, and cytokines (Fisslthaler & Fleming, 2009). In mam
mals, AMPK is a heterotrimeric complex composed of a catalytic subunit
(α), and two regulatory subunits (β and γ) (Hardie, 2007). Phosphory
lation of Thr172, which lies in the activation loop of the α-subunit is
required for AMPK activation (Stein, Woods, Jones, Davison, & Carling,
2000). During the last decade, a number of upstream kinase activities
have been identified (Mihaylova & Shaw, 2011). Among them, calcium/
calmodulin-dependent protein kinase kinase (CAMKK) and liver kinase
B1 (LKB1) are now widely accepted to be the predominant AMPK up
stream kinases (Carling, Sanders, & Woods, 2008). Previous studies have
shown that both LKB 1 and CAMKK exist in endothelial cells and mediate
AMPK activation under different conditions (Stahmann, Woods, Carling,
& Heller, 2006). In vitro studies have demonstrated that activated AMPK
can prevent oxidative stress injury in HAECs via increased phosphory
lation of eNOS at Ser1177 (Li, Reif, Craige, Kant, & Keaney, 2016). A
3
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Fig. 3. The expression and activity of Akt, AMPK and in HAECs treated with sodium nitrite (0.1 µM and 1 µM, 24hr). (A) Western blot protein expression of total
AMPK, phosphorylated AMPK (Thr172), total Akt, phosphorylated Akt (Ser473), total ACC and phosphorylated ACC (Ser79) and in HAECs. (B) The density of the
western blotting band analyzed by Image Lab. Values are expressed as means ± SEM, n = 4/group, *p < 0.05 vs control. p-Akt: phosphorylated Protein kinase B; Akt:
Protein kinase B; p-AMPK: phosphorylated 5′ adenosine monophosphate-activated protein kinase; AMPK: 5′ adenosine monophosphate-activated protein kinase; pACC: phosphorylated acetyl-CoA carboxylase; ACC: acetyl-CoA carboxylase; HAECs: human aortic endothelial cells.

Fig. 4. The expression and activity of phosphorylated AMPK and phosphorylated eNOS in HAECs treated with sodium nitrite (1 µM, 24hr) in the presence and
absence of AICAR (AMPK activator, 1.25 mM) or Compound C (20 µM). (A) Western blot protein expression of total AMPK, phosphorylated AMPK (Thr172), total
eNOS and phosphorylated eNOS (Ser117) in HAECs. (B) The density of the western blotting band analyzed by Image Lab. Valures are expressed as means ± SEM,
n = 4/group, *p < 0.05 vs control, #p < 0.05 presence of inhibitor vs respective treatment. p-eNOS: phosphorylated endothelial nitric oxide synthase; eNOS:
endothelial nitric oxide synthase; p-AMPK: phosphorylated 5′ adenosine monophosphate-activated protein kinase; AMPK: 5′ adenosine monophosphate-activated
protein kinase; HAECs: human aortic endothelial cells; AICAR: 5-Aminoimidazole-4-carboxamide ribonucleotide; Compound C: dorsomorphin.

recent study has shown that nitrite restored phosphorylated AMPK
levels in steatosis HepG2 cells (Cordero-Herrera et al., 2019). This
supports our present findings, where we saw increased AMPK

phosphorylation at significantly lower doses of nitrite, in a human cell
line that is more directly related to cardiovascular disease. Prolonged
supplementation with 10 μM nitrite can also increase activation of
4
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AMPK in insulin-resistant human skeletal muscle cells (Lai et al., 2016).
It has also been reported that AMPK can be activated to stimulate
mitochondrial biogenesis in response to nitrite exposure (50 μM, 3hr) in
rat aortic smooth muscle cells under hypoxic conditions (Mo et al.,
2012). The protection mediated by nitrite and thought to be dependent
on AMPK activation is optimized under the conditions of anoxia and low
pH. In addition, nitrite not only confers cardioprotection when admin
istered during ischaemia, but also when transiently present hours prior
to the onset of an ischaemic episode (Kamga Pride et al., 2014).
Consistent with our results, nitrite activates AMPK in normoxia, but the
underlying mechanisms are unclear. When intracellular ATP is low,
AMPK might be activated by both LKB1 and CAMKK. As a result, acti
vated AMPK mediates eNOS activation in a LKB1 dependent manner
(Thors, Halldorsson, & Thorgeirsson, 2011). Conversely, under condi
tions where intracellular ATP is unchanged, there is less NO generation
and activation of AMPK is only dependent on CAMKK. Thus eNOS is
phosphorylated and activated independently of AMPK (Thors et al.,
2011). Although we did not measure ATP concentration in culture
media, it may be speculated that ATP levels will be decreased by nitrite
stimulation over time. Thus, it is likely that eNOS phosphorylation is
AMPK dependent and this is supported by the fact that the activation of
AMPK and eNOS were almost completely abolished by treatment with
Compound C. Unfortunately due to the gas phase chemilluminescence
methodology used to measure NOx we were unable to confirm increased
NO production in our study as the concentration of NOx measured in the
culture media also included the nitrite which was added to the cells
(data not shown).
It is well-established that the phosphatidylinositol 3-kinase (PI3K)–
Akt cascade is a commonly activated signalling pathway that regulates
eNOS activation in endothelial cells (Fleming & Busse, 2003). eNOS Ser
1177 has been shown to be phosphorylated by Akt as well as AMPK
(Zhang et al., 2009). However, Akt is unlikely to promote eNOS acti
vation mediated by nitrite, as no significant change in Akt phosphory
lation levels was detected following nitrite treatment. Therefore, nitrite
is proposed to mediate eNOS activation in an AMPK-dependent, but not
Akt-dependent manner. AMPK’s role as an energy sensor has been well
established in many tissues and organs such as the skeletal muscle and
heart. However, its exact role in endothelial cell metabolism remains
incompletely understood. It is believed that endothelial cells exist in a
more or less permanent state of “metabolic hypoxia” (Fisslthaler &
Fleming, 2009) and AMPK may have a more important role in the
maintenance of endothelial function. AMPK is the only kinase identified
to date that can potentially phosphorylate eNOS on Ser633 (Chen et al.,
2009) which might be more efficacious than Ser1177 in augmenting the
eNOS-derived NO bioavailability (Bauer et al., 2003). Furthermore,
phosphorylation of Ser633 seems to occur after eNOS Ser1177 phos
phorylation, where this post-translational modification of Ser633 is
proposed to maintain persistent eNOS activity after its initial activation
(Boo et al., 2002). Future investigation is needed to clarify whether
phosphorylation of Ser633 is stimulatory for eNOS activity by nitrite
stimulation.
In conclusion, we have shown that nitrite at physiological concen
trations is an activator of the AMPK–eNOS pathway in human aortic
endothelial cells. Nitrite, may increase NO production via activating
AMPK, followed by eNOS activation in addition to non-enzymatic
pathway as previously reported. The AMPK–eNOS activation by nitrite
could be a potential molecular mechanism underlying the car
dioprotective effects of dietary nitrate.

This work did not include any human or animal subjects or samples.
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